BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meier NR, Jacobsen M, Ottenhoff THM, Ritz N. A Systematic Review on Novel Mycobacterium tuberculosis Antigens and Their Discriminatory Potential for the Diagnosis of Latent and Active Tuberculosis. Front Immunol 2018;9:2476. [PMID: 30473692 DOI: 10.3389/fimmu.2018.02476] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Adankwah E, Lundtoft C, Güler A, Franken KLMC, Ottenhoff THM, Mayatepek E, Owusu-Dabo E, Phillips RO, Nausch N, Jacobsen M. Two-Hit in vitro T-Cell Stimulation Detects Mycobacterium tuberculosis Infection in QuantiFERON Negative Tuberculosis Patients and Healthy Contacts From Ghana. Front Immunol 2019;10:1518. [PMID: 31333654 DOI: 10.3389/fimmu.2019.01518] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Alvarez AH. Revisiting tuberculosis screening: An insight to complementary diagnosis and prospective molecular approaches for the recognition of the dormant TB infection in human and cattle hosts. Microbiol Res 2021;252:126853. [PMID: 34536677 DOI: 10.1016/j.micres.2021.126853] [Reference Citation Analysis]
3 Zhou F, Xu X, Cui X, Pan W. Development and Evaluation of a Fusion Polyprotein Based on HspX and Other Antigen Sequences for the Serodiagnosis of Tuberculosis. Front Immunol 2021;12:726920. [PMID: 34671347 DOI: 10.3389/fimmu.2021.726920] [Reference Citation Analysis]
4 Carranza C, Pedraza-Sanchez S, de Oyarzabal-Mendez E, Torres M. Diagnosis for Latent Tuberculosis Infection: New Alternatives. Front Immunol 2020;11:2006. [PMID: 33013856 DOI: 10.3389/fimmu.2020.02006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
5 Coppola M, Villar-Hernández R, van Meijgaarden KE, Latorre I, Muriel Moreno B, Garcia-Garcia E, Franken KLMC, Prat C, Stojanovic Z, De Souza Galvão ML, Millet JP, Sabriá J, Sánchez-Montalva A, Noguera-Julian A, Geluk A, Domínguez J, Ottenhoff THM. Cell-Mediated Immune Responses to in vivo-Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups. Front Immunol 2020;11:103. [PMID: 32117257 DOI: 10.3389/fimmu.2020.00103] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Namuganga AR, Chegou NN, Mayanja-Kizza H. Past and Present Approaches to Diagnosis of Active Pulmonary Tuberculosis. Front Med (Lausanne) 2021;8:709793. [PMID: 34631731 DOI: 10.3389/fmed.2021.709793] [Reference Citation Analysis]
7 Sousa J, Saraiva M. Paradigm changing evidence that alter tuberculosis perception and detection: Focus on latency. Infect Genet Evol 2019;72:78-85. [PMID: 30576838 DOI: 10.1016/j.meegid.2018.12.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Meier NR, Battegay M, Ottenhoff THM, Furrer H, Nemeth J, Ritz N. HIV-Infected Patients Developing Tuberculosis Disease Show Early Changes in the Immune Response to Novel Mycobacterium tuberculosis Antigens. Front Immunol 2021;12:620622. [PMID: 33777000 DOI: 10.3389/fimmu.2021.620622] [Reference Citation Analysis]
9 Morgan J, Muskat K, Tippalagama R, Sette A, Burel J, Lindestam Arlehamn CS. Classical CD4 T cells as the cornerstone of antimycobacterial immunity. Immunol Rev 2021;301:10-29. [PMID: 33751597 DOI: 10.1111/imr.12963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Gong W, Wu X. Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy. Front Microbiol 2021;12:745592. [PMID: 34745048 DOI: 10.3389/fmicb.2021.745592] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Diesch T, Filippi C, Fritschi N, Filippi A, Ritz N. Cytokines in saliva as biomarkers of oral and systemic oncological or infectious diseases: A systematic review. Cytokine 2021;143:155506. [PMID: 33846070 DOI: 10.1016/j.cyto.2021.155506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Sudbury EL, Clifford V, Messina NL, Song R, Curtis N. Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review. J Infect 2020;81:873-81. [PMID: 33007340 DOI: 10.1016/j.jinf.2020.09.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
13 Qi Y, Liu Z, Liu X, Fang Z, Liu Y, Li F. Tuberculosis-Specific Antigen/Phytohemagglutinin Ratio Combined With GeneXpert MTB/RIF for Early Diagnosis of Spinal Tuberculosis: A Prospective Cohort Study. Front Cell Infect Microbiol 2022;12:781315. [DOI: 10.3389/fcimb.2022.781315] [Reference Citation Analysis]
14 Singh M, Bhatt P, Sharma M, Varma-Basil M, Chaudhry A, Sharma S. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis. Infect Genet Evol 2019;74:103930. [PMID: 31228643 DOI: 10.1016/j.meegid.2019.103930] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 Luo Y, Xue Y, Yuan X, Lin Q, Tang G, Mao L, Song H, Wang F, Sun Z. Combination of prealbumin and tuberculosis-specific antigen/phytohemagglutinin ratio for discriminating active tuberculosis from latent tuberculosis infection. Int J Clin Pract 2021;75:e13831. [PMID: 33175465 DOI: 10.1111/ijcp.13831] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
16 Villar-Hernández R, Blauenfeldt T, García-García E, Muriel-Moreno B, De Souza-Galvão ML, Millet JP, Sabriá F, Sánchez-Montalvá A, Ruiz-Manzano J, Pilarte J, Jiménez MA, Centeno C, Martos C, Molina-Pinargote I, González-Díaz YD, Santiago J, Cantos A, Casas I, Guerola RM, Prat C, Andersen P, Latorre I, Ruhwald M, Domínguez J. Diagnostic benefits of adding EspC, EspF and Rv2348-B to the QuantiFERON Gold In-tube antigen combination. Sci Rep 2020;10:13234. [PMID: 32764560 DOI: 10.1038/s41598-020-70204-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Meier NR, Sutter TM, Jacobsen M, Ottenhoff THM, Vogt JE, Ritz N. Machine Learning Algorithms Evaluate Immune Response to Novel Mycobacterium tuberculosis Antigens for Diagnosis of Tuberculosis. Front Cell Infect Microbiol 2020;10:594030. [PMID: 33489933 DOI: 10.3389/fcimb.2020.594030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Alvarez AH, Flores-Valdez MA. Can immunization with Bacillus Calmette-Guérin be improved for prevention or therapy and elimination of chronic Mycobacterium tuberculosis infection? Expert Rev Vaccines 2019;18:1219-27. [PMID: 31826664 DOI: 10.1080/14760584.2019.1704263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Qiu X, Wang H, Tang Y, Su X, Ge L, Qu Y, Mu D. Is interleukin-2 an optimal marker for diagnosing tuberculosis infection? A systematic review and meta-analysis. Ann Med 2020;52:376-85. [PMID: 32700645 DOI: 10.1080/07853890.2020.1800073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Araujo Z, Fernández de Larrea C, López D, Isern-Kebschull J, de Waard JH, Hagel I, Camargo M, Vanegas M, Patarroyo MA. ESAT-6 and Ag85A Synthetic Peptides as Candidates for an Immunodiagnostic Test in Children with a Clinical Suspicion of Tuberculosis. Dis Markers 2021;2021:6673250. [PMID: 34306256 DOI: 10.1155/2021/6673250] [Reference Citation Analysis]
21 Kaushik AC, Wu Q, Lin L, Li H, Zhao L, Wen Z, Song Y, Wu Q, Wang J, Guo X, Wang H, Yu X, Wei D, Zhang S. Exosomal ncRNAs profiling of mycobacterial infection identified miRNA-185-5p as a novel biomarker for tuberculosis. Brief Bioinform 2021:bbab210. [PMID: 34169968 DOI: 10.1093/bib/bbab210] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Katakura S, Kobayashi N, Hashimoto H, Kamimaki C, Tanaka K, Kubo S, Nakashima K, Teranishi S, Watanabe K, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T. Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan. Tuberculosis (Edinb) 2020;125:101992. [PMID: 32957053 DOI: 10.1016/j.tube.2020.101992] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Li Z, Hu J, Liu P, Cui D, Di H, Wu S. Microarray-based selection of a serum biomarker panel that can discriminate between latent and active pulmonary TB. Sci Rep 2021;11:14516. [PMID: 34267288 DOI: 10.1038/s41598-021-93893-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Tang J, Huang Y, Cai Z, Ma Y. Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-γ release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis. PLoS One 2021;16:e0254571. [PMID: 34270559 DOI: 10.1371/journal.pone.0254571] [Reference Citation Analysis]
25 Zhang L, Ma H, Wan S, Zhang Y, Gao M, Liu X. Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection. Chin Med J (Engl) 2021. [PMID: 34802023 DOI: 10.1097/CM9.0000000000001858] [Reference Citation Analysis]
26 Yan WJ, Zhou HY, Yan H. Characterization of and advanced diagnostic methods for ocular tuberculosis and tuberculosis. Int J Ophthalmol 2020;13:1820-6. [PMID: 33215016 DOI: 10.18240/ijo.2020.11.21] [Reference Citation Analysis]
27 Liang T, Chen J, Xu G, Zhang Z, Xue J, Zeng H, Jiang J, Chen T, Qin Z, Li H, Ye Z, Nie Y, Liu C, Zhan X. Immune status changing helps diagnose osteoarticular tuberculosis. PLoS One 2021;16:e0252875. [PMID: 34129634 DOI: 10.1371/journal.pone.0252875] [Reference Citation Analysis]
28 Serena NN, Boschero RA, Santiani MH, Pacce VD, Costa JMDV, Magalhães FB, Wiedmar C, Alban SM, Soccol CR, Soccol VT. High-performance immune diagnosis of tuberculosis: Use of phage display and synthetic peptide in an optimized experimental design. J Immunol Methods 2022;:113242. [PMID: 35182576 DOI: 10.1016/j.jim.2022.113242] [Reference Citation Analysis]
29 Rodríguez-Hernández E, Quintas-Granados LI, Flores-Villalva S, Cantó-Alarcón JG, Milián-Suazo F. Application of antigenic biomarkers for Mycobacterium tuberculosis. J Zhejiang Univ Sci B 2020;21:856-70. [PMID: 33150770 DOI: 10.1631/jzus.B2000325] [Reference Citation Analysis]
30 Downey AM, Kapłonek P, Seeberger PH. MAIT cells as attractive vaccine targets. FEBS Lett 2019;593:1627-40. [DOI: 10.1002/1873-3468.13488] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
31 Yousefi Avarvand A, Khademi F, Tafaghodi M, Ahmadipour Z, Moradi B, Meshkat Z. The roles of latency-associated antigens in tuberculosis vaccines. Indian Journal of Tuberculosis 2019;66:487-91. [DOI: 10.1016/j.ijtb.2019.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Tang J, Huang Y, Jiang S, Huang F, Ma T, Qi Y, Ma Y. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status. Tuberculosis (Edinb) 2020;124:101966. [PMID: 32866942 DOI: 10.1016/j.tube.2020.101966] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Mustafa AS. Immunological Characterization of Proteins Expressed by Genes Located in Mycobacterium tuberculosis-Specific Genomic Regions Encoding the ESAT6-like Proteins. Vaccines (Basel) 2021;9:27. [PMID: 33430286 DOI: 10.3390/vaccines9010027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Luo Y, Tang G, Yuan X, Lin Q, Mao L, Song H, Xue Y, Wu S, Ouyang R, Hou H, Wang F, Sun Z. Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection. Front Cell Infect Microbiol 2021;11:575650. [PMID: 34277462 DOI: 10.3389/fcimb.2021.575650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Adankwah E, Nausch N, Minadzi D, Abass MK, Franken KLMC, Ottenhoff THM, Mayatepek E, Phillips RO, Jacobsen M. Interleukin-6 and Mycobacterium tuberculosis dormancy antigens improve diagnosis of tuberculosis. J Infect 2021;82:245-52. [PMID: 33278400 DOI: 10.1016/j.jinf.2020.11.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
36 Fei B, Zhou L, Zhang Y, Luo L, Chen Y. Application value of tissue tuberculosis antigen combined with Xpert MTB/RIF detection in differential diagnoses of intestinal tuberculosis and Crohn's disease. BMC Infect Dis 2021;21:498. [PMID: 34049506 DOI: 10.1186/s12879-021-06210-8] [Reference Citation Analysis]
37 Martin DR, Sibuyi NR, Dube P, Fadaka AO, Cloete R, Onani M, Madiehe AM, Meyer M. Aptamer-Based Diagnostic Systems for the Rapid Screening of TB at the Point-of-Care. Diagnostics (Basel) 2021;11:1352. [PMID: 34441287 DOI: 10.3390/diagnostics11081352] [Reference Citation Analysis]
38 Counoupas C, Triccas JA. The generation of T-cell memory to protect against tuberculosis. Immunol Cell Biol 2019;97:656-63. [PMID: 31127962 DOI: 10.1111/imcb.12275] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
39 Sun L, Qi X, Guo Y, Qi H, Li J, Wu X, Yin Q, Guo Y, Xu B, Wang Y, Jin Q, Gao L, Shen A. Tuberculosis infection screening in children with close contact: a hospital-based study. BMC Infect Dis 2021;21:815. [PMID: 34388985 DOI: 10.1186/s12879-021-06480-2] [Reference Citation Analysis]
40 Wu J, Bai J, Wang W, Xi L, Zhang P, Lan J, Zhang L, Li S. ATBdiscrimination: An in Silico Tool for Identification of Active Tuberculosis Disease Based on Routine Blood Test and T-SPOT.TB Detection Results. J Chem Inf Model 2019;59:4561-8. [PMID: 31609612 DOI: 10.1021/acs.jcim.9b00678] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]